FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Amgen   Epogen   Procrit   Anemia
Syndicate content

Aranesp News

Most Popular Aranesp Story

Amgen's new meds beat estimates as anemia drugs slip

Amgen's ($AMGN) anemia drugs faltered again in the fourth quarter with sales declining 15% on Aranesp and 18% on Epogen. New bone drugs Xgeva and Prolia beat analyst estimates for their first full Read more...

Latest Headlines